The Europe Bioresorbable Polymers Market was valued at $143.2 Million in 2024 and projected to reach to $242.1 Million by 2029, representing a compound annual growth rate of 11.1%. Europe's bioresorbable polymers market is poised for sustained expansion through 2029, supported by regulatory mandates, healthcare innovation, and environmental commitments.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Europe's bioresorbable polymers market is valued at $143.2 million in 2024, with a robust CAGR of 11.1% projected through 2029, reaching $242.1 million. This growth outpaces many global regions, driven by stringent EU regulations favoring sustainable materials.
Europe's advanced regulatory framework, including EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), actively promotes bioresorbable polymer adoption. These standards position Europe as a global benchmark for biocompatible and biodegradable material innovation.
Europe's sophisticated healthcare systems and R&D investments in regenerative medicine drive demand for bioresorbable polymers in orthopedic implants, cardiovascular devices, and tissue engineering. Leading pharmaceutical and medical device manufacturers are headquartered across the region.
Europe's commitment to circular economy principles and sustainability targets accelerates bioresorbable polymer adoption. The EU Green Deal and Extended Producer Responsibility directives incentivize manufacturers to transition from conventional to biodegradable materials.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | PLGA (Type) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 11.6% from 2024 to 2029 |
| Largest Segment | ORTHOPEDIC DEVICES (Application) |
| Market Size Base Year (Billions) | ~USD 0.5 (2024) |
| Revenue Forecast (Billions) | ~USD 0.87 (2029) |
| Segments Covered | Type, Application |
2 segment dimensions are covered across the global market.
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|
| DRUG DELIVERY | 49.9 | 54.8 | 60.6 | 67.3 | 75.3 | 84.4 | 94.7 | 11.6 |
| ORTHOPEDIC DEVICES | 69.8 | 76.1 | 83.5 | 92.2 | 102.3 | 113.8 | 126.7 | 10.7 |
| OTHER APPLICATIONS | 11.3 | 12.3 | 13.5 | 14.9 | 16.6 | 18.5 | 20.6 | 10.9 |
| TOTAL | 131 | 143.2 | 157.6 | 174.4 | 194.1 | 216.6 | 242.1 | 11.1 |
| Country | 2025 size (native) |
|---|---|
| Germany | USD 89.2 Million |
| UK | USD 29.6 Million |
| France | USD 29.5 Million |
| Italy | USD 30.7 Million |
| Russia | USD 17.7 Million |
| Rest Of Europe | USD 45.5 Million |
Europe's bioresorbable polymers market was valued at $143.2 million in 2024 and is expected to reach $242.1 million by 2029.
Europe's bioresorbable polymers market is projected to grow at a compound annual growth rate (CAGR) of 11.1% from 2024 to 2029.
Key drivers include Europe's stringent environmental regulations, advanced healthcare infrastructure, aging populations, R&D investments, and commitment to circular economy principles through initiatives like the European Green Deal.
Primary applications in Europe include surgical implants, drug delivery systems, tissue engineering scaffolds, and medical devices that require biodegradable and biocompatible materials.
Germany, France, and the United Kingdom are among the key markets in Europe driving adoption and innovation in bioresorbable polymers due to advanced healthcare systems and strong regulatory frameworks.
The study involved four major activities in estimating the market size for bioresorbable polymers market. Exhaustive secondary research was done to collect information on the market, the peer market, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, the market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary sources used in this study included annual reports, press releases, and investor presentations of companies; white papers; certified publications; articles from recognized authors; and gold standard & silver standard websites such as Factiva, ICIS, Bloomberg, and others. The findings of this study were verified through primary research by conducting extensive interviews with key officials such as CEOs, VPs, directors, and other executives. The breakdown of profiles of the primary interviewees is illustrated in the figure below:
The bioresorbable polymers market comprises several stakeholders, such as raw material suppliers, end-product manufacturers, and regulatory organizations in the supply chain. The demand side of this market is characterized from key opinion leaders in various applications for the bioresorbable polymers market. The supply side is characterized by advancements in technology and diverse application industries. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.
The following is a breakdown of the primary respondents:
Note: Tier 1, Tier 2, and Tier 3 companies are classified based on their market revenue in 2022/ 2023, available in the public domain, product portfolios, and geographical presence.
Other designations include consultants and sales, marketing, and procurement managers.
To know about the assumptions considered for the study, download the pdf brochure
| COMPANY NAME | DESIGNATION | |
|---|---|---|
| Evonik Industries AG | Sales Manager | |
| Ashland Global Holdings Inc. | R&D Manager | |
| KLS Martin Group | Global R&D Head | |
| DSM Biomedical | Business Development Manager | |
| Poly-Med Incorporated | Regional Sales Manager | |
Both top-down and bottom-up approaches were used to estimate and validate the total size of the bioresorbable polymers market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the bioresorbable polymers industry.
The bioresorbable polymers are the type of polymers. They are designed to naturally degrade and be absorbed within biological environments. These polymers are utilized in medical and healthcare sectors, where they are used to manufacture orthopedic devices and drug delivery systems. The demand of bioresorbable polymers influenced by the innovation in medical devices and the need for the eco-friendly alternatives to the permanent implants. The key components of the bioresorbable polymers are PLA, PGA, PLGA, and PCL.
Full forecast, segment splits, and company analysis for all Bioresorbable Polymers Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report